| |
| |
|
| Insider
Information: |
Farzaneh-Far Ramin |
| Relationship: |
Chief Medical Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ra Pharmaceuticals, Inc. |
RARX |
Chief Medical Officer |
2020-04-02 |
0 |
2019-02-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2020-04-02 |
4 |
D |
$48.00 |
$695,616 |
D/D |
(14,492) |
0 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2020-03-16 |
4 |
AS |
$45.16 |
$478,521 |
D/D |
(10,595) |
7,132 |
0 |
% |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2020-03-16 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2020-02-18 |
4 |
AS |
$46.61 |
$493,850 |
D/D |
(10,595) |
7,132 |
0 |
% |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2020-02-18 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2020-01-15 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2020-01-15 |
4 |
AS |
$46.95 |
$497,441 |
D/D |
(10,595) |
7,132 |
0 |
% |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2019-12-16 |
4 |
AS |
$47.23 |
$500,351 |
D/D |
(10,595) |
7,132 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2019-12-16 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2019-11-15 |
4 |
AS |
$46.66 |
$494,319 |
D/D |
(10,595) |
7,132 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2019-11-15 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2019-10-15 |
4 |
AS |
$46.89 |
$496,769 |
D/D |
(10,595) |
7,132 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2019-10-15 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2019-09-16 |
4 |
AS |
$25.26 |
$267,675 |
D/D |
(10,595) |
7,132 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2019-09-16 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2019-08-23 |
4 |
AS |
$27.77 |
$294,226 |
D/D |
(10,595) |
7,132 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2019-08-23 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2019-07-15 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2019-07-15 |
4 |
AS |
$32.97 |
$350,647 |
D/D |
(10,595) |
7,132 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2019-06-17 |
4 |
AS |
$21.41 |
$231,384 |
D/D |
(10,595) |
7,132 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2019-06-17 |
4 |
OE |
$5.60 |
$59,332 |
D/D |
10,595 |
17,727 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2019-02-01 |
4 |
D |
$21.00 |
$68,985 |
D/D |
(3,285) |
7,132 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
Chief Medical Officer |
• – – |
2019-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,417 |
10,417 |
0 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
